BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21903971)

  • 1. Serum osteoprotegerin and sex steroid levels in patients with prostate cancer.
    Varsavsky M; Reyes-Garcia R; Avilés Perez MD; Gonzalez Ramírez AR; Mijan JL; Muñoz-Torres M
    J Androl; 2012; 33(4):594-600. PubMed ID: 21903971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SHBG levels are associated with bone loss and vertebral fractures in patients with prostate cancer.
    Varsavsky M; Reyes-García R; García-Martín A; González-Ramírez AR; Avilés-Perez MD; Muñoz-Torres M
    Osteoporos Int; 2013 Feb; 24(2):713-9. PubMed ID: 22588185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the serum sex steroids, IL-7 and RANKL-OPG system after bone marrow transplantation: influences on bone and mineral metabolism.
    Baek KH; Oh KW; Lee WY; Tae HJ; Rhee EJ; Han JH; Cha BY; Kim YJ; Lee KW; Son HY; Kang SK; Kim CC; Kang MI
    Bone; 2006 Dec; 39(6):1352-60. PubMed ID: 16905375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
    Fahrleitner A; Prenner G; Kniepeiss D; Iberer F; Tscheliessnigg KH; Piswanger-Sölkner C; Obermayer-Pietsch B; Leb G; Dobnig H
    Wien Klin Wochenschr; 2002 Aug; 114(15-16):717-24. PubMed ID: 12602117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis.
    Franck H; Meurer T; Hofbauer LC
    J Rheumatol; 2004 Nov; 31(11):2236-41. PubMed ID: 15517638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women.
    Rogers A; Saleh G; Hannon RA; Greenfield D; Eastell R
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4470-5. PubMed ID: 12364420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status.
    Szulc P; Hofbauer LC; Heufelder AE; Roth S; Delmas PD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3162-5. PubMed ID: 11443182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population.
    Gannagé-Yared MH; Fares F; Semaan M; Khalife S; Jambart S
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):652-8. PubMed ID: 16712667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystatin C as a potential predictor of osteoprotegerin levels in healthy men, a cross-sectional, observational study.
    Kulcsar-Jakab E; Petho Z; Pap Z; Kalina E; Foldesi R; Balogh A; Antal-Szalmas P; Bhattoa HP
    BMC Musculoskelet Disord; 2015 Aug; 16():227. PubMed ID: 26311162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerostin serum levels in prostate cancer patients and their relationship with sex steroids.
    García-Fontana B; Morales-Santana S; Varsavsky M; García-Martín A; García-Salcedo JA; Reyes-García R; Muñoz-Torres M
    Osteoporos Int; 2014 Feb; 25(2):645-51. PubMed ID: 23903956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical bone status is associated with serum osteoprotegerin concentration in men: the STRAMBO study.
    Szulc P; Hawa G; Boutroy S; Vilayphiou N; Schoppet M; Chapurlat R; Hofbauer LC
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2216-26. PubMed ID: 21565793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex steroids and bone turnover markers in men with symptomatic vertebral fractures.
    Tuck SP; Scane AC; Fraser WD; Diver MJ; Eastell R; Francis RM
    Bone; 2008 Dec; 43(6):999-1005. PubMed ID: 18817902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlates of osteoprotegerin levels in women and men.
    Khosla S; Arrighi HM; Melton LJ; Atkinson EJ; O'Fallon WM; Dunstan C; Riggs BL
    Osteoporos Int; 2002 May; 13(5):394-9. PubMed ID: 12086350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of androgen deprivation therapy on serum levels of sclerostin, Dickkopf-1, and osteoprotegerin: a cross-sectional and longitudinal analysis.
    Wang A; Karunasinghe N; Plank LD; Zhu S; Osborne S; Brown C; Bishop K; Schwass T; Tijono S; Holmes M; Masters J; Huang R; Keven C; Ferguson LR; Lawrenson R
    Sci Rep; 2021 Jul; 11(1):14905. PubMed ID: 34290287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral density and serum levels of soluble tumor necrosis factors, estradiol, and osteoprotegerin in postmenopausal women with cirrhosis after viral hepatitis.
    González-Calvin JL; Mundi JL; Casado-Caballero FJ; Abadia AC; Martin-Ibañez JJ
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4844-50. PubMed ID: 19897681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional study of bone turnover during bicalutamide monotherapy for prostate cancer.
    Smith MR; Fallon MA; Goode MJ
    Urology; 2003 Jan; 61(1):127-31. PubMed ID: 12559282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum osteoprotegerin is a major determinant of bone density development and prevalent vertebral fracture status following cardiac transplantation.
    Fahrleitner A; Prenner G; Leb G; Tscheliessnigg KH; Piswanger-Sölkner C; Obermayer-Pietsch B; Portugaller HR; Berghold A; Dobnig H
    Bone; 2003 Jan; 32(1):96-106. PubMed ID: 12584041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status.
    Fahrleitner-Pammer A; Dobnig H; Piswanger-Soelkner C; Bonelli C; Dimai HP; Leb G; Obermayer-Pietsch B
    Wien Klin Wochenschr; 2003 May; 115(9):291-7. PubMed ID: 12793029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption.
    Anderson FH; Francis RM; Peaston RT; Wastell HJ
    J Bone Miner Res; 1997 Mar; 12(3):472-8. PubMed ID: 9076591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum osteoprotegerin and its ligand in cirrhotic patients referred for orthotopic liver transplantation: relationship with metabolic bone disease.
    Monegal A; Navasa M; Peris P; Alvarez L; Pons F; Rodés J; Guañabens N
    Liver Int; 2007 May; 27(4):492-7. PubMed ID: 17403189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.